Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk Yadong WangHaiyan YangHaiyu Wang Editorial 18 March 2015 Pages: 467 - 471
Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome Jacques RaphaelS. Verma Review 19 March 2015 Pages: 473 - 478
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer X. ZhuL. ShanH. Yang Preclinical Study 18 March 2015 Pages: 479 - 486
Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells Samaya R. KrishnanBinoj C. NairRatna K. Vadlamudi Preclinical study 19 March 2015 Pages: 487 - 499
miR-153 inhibits epithelial–mesenchymal transition by targeting metadherin in human breast cancer Wentong LiLimin ZhaiShijun Lv Preclinical study 21 March 2015 Pages: 501 - 509
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer Rezvan AbduljabbarMethaq Mueen Al-KaabiEmad Rakha Preclinical study 21 March 2015 Pages: 511 - 522
Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells Manisha H. ShahGuei-Sheung LiuHitesh M. Peshavariya Preclinical study 21 March 2015 Pages: 523 - 534
Targeting thyroid hormone receptor beta in triple-negative breast cancer Guowei GuLuca GelsominoSuzanne A. W. Fuqua Preclinical study 28 March 2015 Pages: 535 - 545
Retrospective analysis of metastatic behaviour of breast cancer subtypes C. Dilara Savci-HeijinkHans HalfwerkMarc J. van de Vijver Preclinical Study Open access 29 March 2015 Pages: 547 - 557
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer Sarah J. ConleyTrenton L. BakerMax S. Wicha Preclinical study 02 April 2015 Pages: 559 - 567
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers Jennifer StanleyLisa KlepczykEddy S. Yang Preclinical Study 02 April 2015 Pages: 569 - 579
Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes Qijia XuanHongfei JiQingyuan Zhang Clinical Trial 12 March 2015 Pages: 581 - 588
Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection Vered StearnsAmanda BlackfordDavid Eisner Clinical Trial 20 March 2015 Pages: 589 - 595
The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy Luke J. PepponeMichelle C. JanelsinsKaren M. Mustian Clinical trial 27 March 2015 Pages: 597 - 604
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer Ana Elisa LohmannJudy-Anne W. ChapmanPamela Jean Goodwin Clinical trial 02 April 2015 Pages: 605 - 611
The association between diabetes and breast cancer stage at diagnosis: a population-based study Lorraine L. LipscombeHadas D. FischerLawrence Paszat Epidemiology 17 March 2015 Pages: 613 - 620
Impact of breast cancer subtypes and patterns of metastasis on outcome Karin KastTheresa LinkPauline Wimberger Epidemiology 18 March 2015 Pages: 621 - 629
Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers Yael LaitmanLital Keinan BokerEitan Friedman Epidemiology 19 March 2015 Pages: 631 - 635
Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry C. SnyderK. MetcalfeH. T. Lynch Epidemiology 21 March 2015 Pages: 637 - 641
Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women Bernard RosnerA. Heather EliassenGraham A. Colditz Epidemiology Open access 22 March 2015 Pages: 643 - 653
Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium Elisa V. BanderaUrmila ChandranLynn Rosenberg Epidemiology 26 March 2015 Pages: 655 - 666
Race, response to chemotherapy, and outcome within clinical breast cancer subtypes J. R. TichyA. M. DealL. A. Carey Epidemiology 27 March 2015 Pages: 667 - 674
Personality and breast cancer risk and survival: the Miyagi Cohort Study Yuko MinamiToru HosokawaIchiro Tsuji Epidemiology 01 April 2015 Pages: 675 - 684
Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer Ramkishore GernapudiYuan YaoQun Zhou Brief Report 18 March 2015 Pages: 685 - 695
Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer Cynthia Villarreal-GarzaDaniel KhalafRebecca Dent Erratum 26 March 2015 Pages: 697 - 697
Erratum to: Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history Peter Choon Eng KangSze Yee PhuahSoo Hwang Teo Erratum 02 April 2015 Pages: 699 - 700
